Pushti Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.86 Cr
- Satisfied Charges ₹ 1.94 Cr
- Revenue Growth 66.40%
- Profit Growth 24.11%
- Ebitda 41.93%
- Net Worth 53.55%
- Total Assets 34.60%
About Pushti Pharmachem
Pushti Pharmachem Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 December 2014 and has a history of Ten years and two months. Its registered office is in Shajapur, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.86 Cr. The company has closed loans amounting to ₹1.94 Cr, as per Ministry of Corporate Affairs (MCA) records.
Maulik Savani and Dilip Moradia serve as directors at the Company.
Company Details
- Location
Shajapur, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100MP2014PTC033598
- Company No.
033598
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Dec 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Pushti Pharmachem?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dilip Moradia  | Director | 29-Apr-2017 | Current |
| Maulik Savani | Director | 29-Apr-2017 | Current |
Financial Performance of Pushti Pharmachem.
Pushti Pharmachem Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 66.4% increase. The company also saw a substantial improvement in profitability, with a 24.11% increase in profit. The company's net worth Soared by an impressive increase of 53.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pushti Pharmachem?
In 2021, Pushti Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Moradiya Chemicals Private LimitedDilip Moradia is a mutual person
Charges (Loans)
₹18.62 M
₹19.35 M
Charges Breakdown by Lending Institutions
- Others : 1.86 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jan 2024 | Others | ₹1.86 Cr | Open |
| 09 Jun 2021 | Hdfc Bank Limited | ₹1.29 Cr | Satisfied |
| 21 Dec 2017 | Others | ₹6.50 M | Satisfied |
How Many Employees Work at Pushti Pharmachem?
Unlock and access historical data on people associated with Pushti Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pushti Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pushti Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
